PMID-sentid	Pub_year	Sent_text		comp_official_name	comp_offsetprotein_name	organism	prot_offset
27502582-0	2016	Evaluation of two doses of etoricoxib, a COX-2 selective non-steroidal anti-inflammatory drug (NSAID), in the treatment of Rheumatoid Arthritis in a double-blind, randomized controlled trial.	Etoricoxib	27-37	mitochondrially encoded cytochrome c oxidase II	Homo sapiens	41-46	
27502582-2	2016	Etoricoxib is a COX-2 selective NSAID that has demonstrated efficacy in the treatment of RA at a dose of 90 mg.	Etoricoxib	0-10	mitochondrially encoded cytochrome c oxidase II	Homo sapiens	16-21